Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

These RCT findings support safety and efficacy in 6 to 12 year olds, but there are many unanswered questions, one expert says ...

Currently, there are no approved medications for treating nonmonogenic, nonsyndromic obesity in children under 12. While ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

THURSDAY, Sept. 12, 2024 (HealthDay News) — Liraglutide plus lifestyle intervention is efficacious for children aged 6 to <12 ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...